zemplar 2 micrograms capsules, soft
abbvie spain s.l.u. - Прием парикальцитола - 2 micrograms capsules, soft
chirocaine 5 mg/ml solution for injection/concentrate for slution for infusion
abbvie s.r.l. - хлорхидрат levobupivacaine - 5 mg/ml solution for injection/concentrate for slution for infusion
chirocaine 7,5 mg/ml solution for injection/concentrate for slution for infusion
abbvie s.r.l. - хлорхидрат levobupivacaine - 7,5 mg/ml solution for injection/concentrate for slution for infusion
duodopa 20 mg/ml + 5 mg/ml intestinal gel
abbvie deutschland gmbh & co.kg - Леводопа и инхибитори на декарбоксилазы - 20 mg/ml + 5 mg/ml intestinal gel
survanta 25 mg / ml endotracheopumonary inst. susp.
abbvie ltd - Природни фосфолипиди - 25 mg / ml endotracheopumonary inst. susp.
forane 100 % inhalation vapour, liquid
abbvie ltd - Изофлуран - 100 % inhalation vapour, liquid
sevorane 100% inhalation vapour, liquid
abbvie ltd - Севофлуран - 100% inhalation vapour, liquid
lucrin depot 3,75 mg powder and solvent for suspension for injection
abbvie ltd - Лейпрорелин - 3,75 mg powder and solvent for suspension for injection
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - Артрит, ревматоиден - Имуносупресори - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
revitacam
zoetis belgium sa - мелоксикам - oxicams - Кучета - За облекчаване на възпалението и болката при остри и хронични мускулно-скелетни нарушения при кучета.